Unsupported browser detected
Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to carry out experimental studies in humans to determine if and how novel adjuvant and HIV-1 envelope immunogen combinations can induce higher levels, longer lasting, and qualitatively improved HIV-1 antibodies that may protect against HIV-
Grantee
Division
Global Health
Date
NOVEMBER 2014
Region Served
GLOBAL
Committed Amount
$4,740,863
Grant Topic
HIV
Duration (Months)
96
Grantee Location
Seattle, Washington, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.